values of 0.006 and 0.024 ppm, respectively. Bsph exhibited little toxicity against Ae. eagypti larvae and also no toxicity to Bsph resistance. In the Þeld, we evaluated four experimental corn grit formulations of Bti (VBC 60021), Bsph (VBC 60022), UCR recombinants VBC 60023 (7.89%), and VBC 60024 (1.87%) in simulated Þeld (microcosms) against Bsph-susceptible Culex mosquitoes. Bti and low-concentrate UCR recombinant showed similar initial activity as well as persistence. Both materials provided high-to-moderate level of control for 2Ð7 d posttreatment at low treatment rates. At low dosages, residual activity of Bti and UCR recombinant lasted for Ͻ7 d. Bsph and high-concentrate UCR recombinant (VBC 60023), however, were more effective against natural populations of Culex and achieved longer control (7Ð21 d) than the other two materials.
SINCE THE DISCOVERY OF the mosquitocidal properties of Bacillus thuringiensis ssp. israelensis de Barjac (Bti) and Bacillus sphaericus (Neide) (Bsph), various commercial formulations of these agents have been developed and used for controlling mosquitoes. The advantages of these control agents in terms of efÞcacy, speciÞcity, and environmental safety in mosquito control have been documented (de Barjac and Sutherland 1990) . B. sphaericus exhibited higher activity against Culex mosquitoes and longer persistence in the Þeld against many mosquito species than Bti. To date, at least 17 strains of Bsph have shown high level of activity against mosquito larvae. Strains 1593M, 2362, 2297, and C3-41 have been evaluated extensively during the past several years (de Barjac and Sutherland 1990; Singer 1985 Singer , 1990 Mulla 1986; Rao et al. 1995) and have exhibited high toxicity against mosquito larvae. Bsph strain 2362 was selected for development, formulated, and introduced into mosquito control programs in the early 1990s in Europe, Asia, Africa, and South America (Sinè gre et al. 1994 , Hougard et al. 1993 , Silva-Filha et al. 1995 . In 1997, formulations based on this strain were introduced in the United States.
Large-scale Þeld trials on various formulations of Bsph strain 2362 have been conducted in a number of countries where this strain was found to perform well in controlling mosquitoes breeding in various habitats, especially those in polluted waters. However, emergence of resistance in Culex pipiens complex in some tropical and temperate regions has been reported in laboratory and Þeld populations (Rodcharoen and Mulla 1994 , Sinè gre et al. 1994 , Rao et al. 1995 , Silva-Filha et al. 1995 , Wirth et al. 2000a , Yuan et al. 2000 . Wirth et al. (2000b) reported that the combination of Bsph (2362) with CytlA protein of Bti in a 10:1 ratio reversed Bsph resistance in a highly resistant Culex quinquefasciatus (Say) population. To exploit this combination (B.A.F. et al., unpublished data), devel-oped a construct of Bti/Bsph that produces both the binary toxins of Bsph and Cyt1A toxin of Bti, which suppresses high level of resistance to Bsph in Cx. quinquefasciatus. Studies on the reversion of acquired Bsph resistance in mosquitoes showed rapid decline in resistance on selection of the resistant mosquitoes with mixtures of Bti and Bsph (Zahiri et al. 2002) . Results of these studies indicated that these strategies may provide a practical solution to Bsph resistance in mosquito populations.
A recent study (Zahiri and Mulla 2003) on selection of susceptible California Cx. quinquefasciatus with a mixture of Bti and Bsph for up to 36 generations showed that development of resistance was delayed or prevented to Bsph, whereas selection with rotation of Bti and Bsph every other generation induced rapid and high level of resistance to Bsph. Su and Mulla (2003) showed that the mixture of Bti and Bsph exhibited high levels of activity in killing both Bsphresistant and -susceptible mosquitoes. However, evaluation of different ratios of mixtures indicated that as the amount of Bsph in Bti/Bsph mixtures increased the activity of the mixtures declined progressively in killing Bsph-resistant mosquitoes.
In an effort to develop management strategies for Bsph-resistant larvae, a new Bti/Bsph recombinant (Federici et al. 2004) was constructed. The current study was carried out to assess the activity and efÞcacy of this new Bti/Bsph construct formulation along with commercial formulations of Bsph and Bti against a susceptible strain (Thailand) and highly Bsph-resistant Cx. quinquefasciatus larvae from Northaburi Province, Thailand . To determine the minimum effective dosages and residual activity of these formulations, studies were also carried out against Þeld populations of Culex mosquitoes produced in organically enriched Þeld microcosms (tubs) at the Aquatic and Vector Control Research Facility at the University of California, Riverside, CA.
Materials and Methods
Test Materials. The materials used in laboratory bioassays of Bsph-susceptible and -resistant Cx. quinquefasciatus larvae were technical powders (TPs) of Bti (VS063-1), Bsph (VS063-2), and UCR recombinant (VS063-3), producing both Bti and Bsph mosquitocidal toxins (Federici et al. 2004) . Also four experimental corn grit (CG) formulations of Bti (VBC 60021), Bsph (VBC 60022), UCR recombinants 7.89% (VBC 60023), and 1.87% (VBC 60024) were evaluated in organically enriched water Þlled tubs, set in open sunlight. All formulations were provided by Valent BioSciences Corporation, Libertyville, IL (received on 7 and 12 July 2001 respectively).
Preparation of Stock Suspensions and Dilutions. Stock suspensions for laboratory bioassays were prepared by suspending 200 mg of the test materials (TP) in 20 ml of distilled water (DW) and shaking vigorously by hand, yielding 1% (wt:vol) suspensions. These stock suspensions were then diluted serially (10-fold) with DW, yielding 0.1, 0.01, and 0.001% suspensions. The UCR recombinant (VS063-3) material was sonicated (Fisher sonic dismembrators, model 300, ARTEK Systems Corporation, Farmingdale, NY) because it did not go into suspension by manual shaking. In this case, a 1% suspension in 20 ml of water in a 25-ml glass vial was ultrasonicated at 10% strength (10,000 Ϯ 400 cycles/s) three times for 10 s each time with a 20-s interval between sonications. During this procedure, the vial (1% suspension) was held in an ice bath in a 100-ml beaker to prevent overheating.
All materials and water used in testing the UCR recombinant (TP) in the laboratory were submerged in plastic tubs (placed in a fume hood) in 10% bleach solutions for 24 h before disposal.
Laboratory Bioassays. To gauge the activity of the Bti, Bsph, and the UCR recombinant, bioassays were run against early fourth instars of Bsph-susceptible Cx. quinquefasciatus colonies from Thailand and also against a highly Bsph-resistant colony of Cx. quinquefasciatus from Thailand, with LC 50 and LC 90 values of Ͼ2,000 and Ͼ8,000 ppm Bsph, respectively. The resistant colony was brought to our laboratory from Wat Pikul, Northaburi Province, Thailand, in 2001 without further selection with Bsph.
Bioassays were conducted according to Rodcharoen and Mulla (1994) . Brießy, 20 early fourth instars were transferred to 100 ml of distilled water in a 120-ml disposable waxed paper cup. One drop of larval food (2 g of ground up rabbit pellets in 20 ml of distilled water) was added per cup. The cups were treated with four to six concentrations, depending on the test material and susceptibility of a given strain of mosquitoes, yielding between 10 and 95% mortalities in 24 h for Bti or 48 h for Bsph and UCR recombinant preparations. Bioassays were carried out on three or four different occasions. The bioassay cups were held at 27Ð28ЊC. Moribund larvae were counted as dead. If mortality in the control exceeded 5%, the test was discarded. The doseÐresponse data were subjected to probit regression analysis using POLO-PC (LeOra Software 1987). The slope, lethal concentrations (LC 50 and LC 90 ), and their 95% conÞdential intervals were calculated using this software.
Field Evaluations. Four Þeld experiments against natural populations of Culex (Cx. quinequefasciatus, Culex tarsalis Coquillett, and Culex stigmatosoma Speiser) larvae were carried out in 25 Þberglass tubs (microcosms). The units were located in an open sunlit area at the Aquatic and Vector Control Research Facility. Before each experiment, the tubs were cleaned thoroughly, dried, and Þlled with water from an irrigation reservoir. To increase mosquito oviposition, the tubs were enriched with rabbit pellets at the rate of 100 g per tub at the start of each experiment. However, during the third experiment (14 d posttreatment), the tubs were again enriched with 100 g because of low number of larvae. The tubs treated with the UCR recombinants were sterilized with one liter of bleach (sodium hypochlorite 5.25%) for 3Ð 4 h before draining. The water surface in the tubs was 8,361.3 cm 2 (9 square feet), 30.5 cm (12 inches in depth), and contained 240 liters of water from a reservoir. The water level was kept constant in the tubs with ßoat valves.
Field Treatments. Experiment 1 (071101) was initiated on 11 July 200, in 25 Þberglass tubs. The tubs were Þlled with water for testing the efÞcacy of the CG formulations of Bti, and Bsph (two dosages each). On 16 July, 5 d after ßooding the tubs, mosquito larval density was checked. Large numbers of Þrst through fourth instars were present without pupae. Each of the treatments and control were assigned to the tubs at random with Þve replicates in experiments 1, 2, and 4, and four replicates in experiment 3. After each experiment (except experiment 3), the tubs were washed and cleaned as described above.
In the Þrst test (experiment 071101), we evaluated Bti CG at the rates of 5.3 and 10.6 lb/acre and Bsph CG formulation at the lower rates of 2.7 and 5.3 lb/acre. Treatments were made on 17 July and this experiment was terminated on 31 July 2001. In the second test (experiment 080201), we evaluated Bsph (CG) and the UCR recombinant CG (VBC 60024, 1.87%) each at the rates of 1.4 and 2.7 lb/acre. Immature mosquitoes were sampled from 2 August to 14 August 2001. The third test (experiment 081601) was conducted using Bsph (CG) at the rates of 2.7 and 5.3 lb/acre and the UCR recombinant (VBC 60024, 1.87%) at the rates of 2.7, 5.3, and 10.6 lb/acre. The experiment was terminated on 17 September 2001. The last experiment (experiment 091701) was conducted after the termination of experiment 081601, without cleaning the tubs because larval and pupal populations were very low at the end of this experiment on 16 August 2001. In the fourth experiment, Bsph was applied at 5.3 lb/acre, whereas the UCR recombinant (VBC-60023, 7.89%) was applied at 1.4, 2.7, and 5.3 lb/acre. In the Þrst three experiments, the tubs were treated 5Ð 6 d after ßooding when third and early fourth instars were present in large numbers, but in the fourth experiment, which was a continuation of the third, both larvae and pupae prevailed at high numbers during the administration of this treatment.
Sampling. Populations of mosquito larvae and pupae were sampled on day 0 (pretreatment), 2, 7, and 14, or other intervals posttreatment, by taking four dip samples per tub. One dip from each corner, (or other spots) where larvae and pupae congregated, was taken. The samples were counted on site and put into three categories: early instars (Þrst and second), late instars (third and fourth), and pupae. Mosquito species composition from the control tubs was determined by identifying Ϸ50 fourth instars on each sampling day.
Data Analysis. Percentage of reductions posttreatment were calculated using the formula of Mulla et al. 1971 : % Reduction ϭ 100 Ϫ (C 1 /C 2 ϫ T 2 /T 1 ) ϫ 100, where C 1 is average number pretreatment in control, C 2 is average posttreatment in control, T 1 is pretreatment in treated, and T 2 is posttreatment in treated. Percentage of control was calculated using the average of late instars (third and fourth) and pupae combined. It is important to note that the absence of pupae is a good indication of control. As mentioned above, experiment 4 was started right after the termination of experiment 3 without draining or cleaning the tubs; therefore, there were already many pupae before treatment in experiment 4, and these pupae were included in the calculations.
Water Quality Determinations. During the test period, water quality parameters were determined for all replicates of the control. Factors including dissolved oxygen (percentage), oxygen concentration (milligrams per liter), electrical conductivity (mhos), and salinity (parts per thousand) were measured with a YSI model 85 water quality meter. Water temperatures were measured with a submerged minimum and maximum thermometer in one tub and read every sampling period.
Results and Discussion
Laboratory Bioassays. Bioassay data for Bti (VS063-1) TP against fourth instars of Cx. quinquefasciatus susceptible (S) and resistant (R) to Bsph are presented in Table 1 . The LC 50 values were 0.009 and 0.011 ppm, whereas the LC 90 values were 0.057 and 0.026 ppm for the S and R strains, respectively. Bti displayed similar levels of activity against both strains, causing 90% mortality (24 h) at low concentrations in the range of Ϸ0.026 Ð 0.057 mg/liter. It is interesting to note that the resistant strain was slightly more susceptible to Bti than the susceptible strain at the LC 90 level. It was noted that, Bti TP was also active against Ae. aegypti larvae (data not shown), with LC 50 and LC 90 values of 0.014 and 0.055 ppm, respectively.
The LC 50 values for Bsph (VS063-2) TP against fourth instars of Cx. quinquefasciatus susceptible and In the Þrst experiment (11 July 2001) Bsph (VBC 60022) CG formulation was applied at the rates of 2.7 and 5.3 lb/acre and Bti (VBC 60021) CG formulation at the rates of 5.3 and 10.6 lb/acre. Before treatment, the densities of immature mosquitoes were essentially the same in the tubs assigned to control and treatment regimens. The early instars densities ranged from 52 to 70 and late instars from 76 to 94 per dip. No pupae were present at the time of the treatment (Table 2 ). Bsph at both rates was equally effective on day 2 and 7 of posttreatment, yielding 99 Ð97 and 89 Ð 88% reduction, respectively. The low rate of Bsph was equally effective initially as the high rate of Bti; it yielded higher level of control than Bti at 7 d posttreatment. Bti treatments were short lived; the two rates of 5.3 and 10.6 lb/acre yielded only 59 and 63% reduction 7 d posttreatment, respectively. Bsph treatments were longer lasting, giving higher reductions on day 7 posttreatment, compared with Bti. Reductions with Bsph dosages on day 14 of posttreatment, however, declined and were at 55 and 54%, similar to the reductions caused by Bti on day 14. The Þrst experiment was terminated on day 14 posttreatment because the level of control with both materials was deemed unsatisfactory.
In the second experiment (2 August 2001), a Bsph (VBC 60022) CG and the UCR recombinant VBC 60024 CG (1.87%) formulations were applied at the rates of 1.4 and 2.7 lb/acre (Table 3) . As in the Þrst experiment, the control and treatment tubs had similar larval densities before treatment. The early instars densities were 62Ð90, late instars densities were 45Ð 67 per dip, and pupae were not present (Table 3 ). The reductions in the two dosages of Bsph were 84 Ð78%, and the UCR recombinant reductions were 69 Ð 64% on day 2 posttreatment. On day 7 posttreatment, the C, control; T, treatment; 1, Pretreatment; 2, posttreatment. a Percentage of reduction was calculated based on late instars and pupae in posttreatment compared with pretreatment (Mulla et al. 1971 ), % ϭ 100 Ϫ (C1/T1 ϫ C2/T2) ϫ 100.
UCR recombinant declined in efÞcacy (58 and 30%), but Bsph still had moderate-to-high level of control (94 and 78%). In this experiment, the dosages of the UCR recombinant might have been too low to yield a high level of control. The experiment was not followed further after day 7 posttreatment. From these preliminary studies, it seemed that the longevity of control of the low concentrate recombinant formulation at 1.4 and 2.7 lb/acre rates was lower than Bsph with the same rates (Table 3) .
In the third experiment (16 August 2001), the Bsph (VBC 60022) CG and the UCR recombinant VBC 60024 CG (1.87%) formulations were applied at 2.7 and 5.3 lb/acre for Bsph and at 2.7, 5.3, and 10.6 lb/acre for the UCR recombinant. These rates were higher than those in the previous experiments (Table 4) . In this experiment, pretreatment larval densities were higher than the last two experiments. Before treatment, the early instars densities were 57Ð107 and late instars were 72Ð120 per dip, and as in the previous experiments, there were no pupae present (Table 4) . On day 2 posttreatment, Bsph at both rates and the UCR recombinant at the highest rate were equally effective, yielding 90 Ð98% control. However, the two lower rates of UCR recombinant yielded similar but lower levels of control (76 Ð71%) than the highest rate. (VBC-60022), and UCR recombinant (VBC-60024) CG (1.87%) a Percentage of reduction was calculated based on late instars and pupae in posttreatment compared with pretreatment (Mulla et al. 1971) . On day 7 posttreatment, both rates of Bsph gave 98 Ð 99% control, whereas the UCR recombinant caused mediocre reductions (56 Ð 69%). On day 14 posttreatment, Bsph reductions were 87Ð75% at the rates of 2.7 and 5.3 lb/acre, respectively. The UCR recombinant at the two high rates showed 63 and 57% control, whereas the lower rate yielded only 26%. On days 20 and 23 posttreatment, Bsph still showed good reduction (84 Ð 67%), which was higher than that of the UCR recombinant (59 Ð31%) at the two higher rates. The experiment was terminated 23 d posttreatment when the level of control was deemed unsatisfactory. In the fourth experiment (17 September 2001), the Bsph (VBC 60022) CG formulation was applied at the rate of 5.3 lb/acre and the high concentrate UCR recombinant VBC 60023 CG (7.89%) formulation at the rates of 1.4, 2.7, and 5.3 lb/acre (Table 5 ). The larval densities were relatively high in the pretreatment during this experiment. The early instars densities were 57Ð94 and the late instars densities were 31Ð96 per dip, and the pupae were 19 Ð22 at the time of the start of the fourth experiment (Table 5) . On 2 d posttreatment, Bsph and UCR recombinant at all dosages produced Ͼ92% reductions. Almost similar high level of control (87Ð99%) was achieved in all treatments on 7 d posttreatment. On day 14 posttreatment, the Bsph (5.3 lb/acre) treatment and the UCR recombinant at the 5.3 lb/acre rate yielded 88 and 83% reduction respectively. The UCR recombinant at the two lower rates (1.4 and 2.7 lb/acre) was less effective yielding (64 and 24% reduction). The experiment was terminated after day 14 posttreatment.
Mosquito Composition. Mosquito species compositions are shown in Table 6 . Mosquito species collected from the control tubs in the Þrst Þeld experiment were predominantly Cx. tarsalis, whereas in the second experiment Cx. quinquefasciatus was dominant. In the third and fourth experiments, Cx. tarsalis became dominant again. Cx. stigmatosoma was also present in all experiments except the second one.
Overall, Cx. tarsalis was the most prevalent species breeding in the tubs.
Water Quality. Water quality was measured in all control tubs. In the Þrst experiment, water temperatures ranged from 17 to 32ЊC; in the second and third experiments, the temperatures were from 21 to 32ЊC; and in the fourth experiment, they were from 16 to 31ЊC. The O 2 levels were different between and within the experiments. Generally, O 2 levels increased after the second day of treatments. No difference in electric conductivity was detected between the experiments, and the salinity readings were 02Ð 03 ppt in the control tubs during the test periods. In summary, our laboratory bioassays showed that Bti and the UCR recombinant were equally effective against Bsph-susceptible (Thailand) and -resistant Cx. quinequefasciatus (Thailand) and Ae. aegypti. Bsph was also highly effective against the susceptible strain of Cx. quinequefasciatus. Cx. quinequefasciatus resistant to Bsph and Ae. aegypti larvae were refractory to Bsph. In Þeld microcosm studies, Bti and the low concentrate of UCR recombinant showed almost similar levels of initial activity as well as persistence against susceptible Culex species at the rate of 5.3 lb/acre. Both materials provided moderate levels of control for 2 d posttreatment, but the level of control declined slightly at 7 d posttreatment. However, the high-concentrate UCR recombinant provided a high level of reduction for 2 and 7 d posttreatment at low dosage (92Ð93%), but this UCR recombinant, at high dosage, provided high level of reduction (83%) up to 14 d at the highest dosage. Bsph was more effective at equivalent dosages against Þeld Culex and showed longer control than the other two materials. Although Bti and Bti/Bsph recombinant do not have the same level of efÞcacy and longevity as Bsph in the Þeld, these agents are highly effective against Bsph-resistant mosquitoes, and therefore they offer viable options for the management of Bsph-resistant mosquitoes. These two materials have similar levels of initial activity and longevity of control. Both of these materials also have high levels of activity against Ae. Aegypti, whereas this species is refractory to Bsph.
